* Medifast Inc MED.N MED is expected to show a fall in
quarterly revenue when it reports results on February 21.
* The Owings Mills Maryland-based company is expected to
report
a 12.6% decrease in revenue to $330.1 million from $377.83
million a year ago, according to the estimate from one analyst,
based on Refinitiv data. The company's guidance on August 3
2022, for the period ended December 31, was for revenue between
$377.83 million and $385.39 million.
* Refinitiv's mean analyst estimate for Medifast Inc is for
earnings of $2.22 per share.
* The one available analyst rating on the shares is
"hold".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Medifast
Inc is
$106, below its last closing price of $115.31.
This summary was machine generated February 17 at 22:08 GMT.
All figures in US dollars unless otherwise stated